XML 118 R99.htm IDEA: XBRL DOCUMENT v3.25.0.1
Fair Value of Financial Instruments (Details-4) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]      
Beginning balance $ (2,604) $ (866) $ 178
Realized and unrealized gains (losses):      
Included in regulatory assets 0 (1,738) (1,044)
Included in regulatory liability 2,159 0 0
Included in earnings [1] (6,209) (9,211) 14,140
Included in current assets 0 0 118
Purchases 0 0 11,997
Settlements 6,207 9,211 (26,255)
Ending balance $ (447) $ (2,604) $ (866)
[1] MGE's exchange-traded derivative contracts, over-the-counter party transactions, purchased power agreement, and FTRs are subject to regulatory deferral. These derivatives are therefore marked to fair value and are offset in the financial statements with a corresponding regulatory asset or liability.